EMR showing upside potential
Emerson is half way into the cycle with price target ranging from $93 to $96. I expect earnings to be good, but the recent indication for a hostile acquisition might overshadow the ER. I believe this will trend in a range until mid March when this could start its next leg up.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.